What is the size of the Brucellosis Vaccines market in 2023?

The Brucellosis Vaccines market size is USD 242 million in 2023.

What is the projected CAGR at which the Brucellosis Vaccines market is expected to grow at?

The Brucellosis Vaccines market is expected to grow at a CAGR of 5.2% (2024-2033).

List the segments encompassed in this report on the Brucellosis Vaccines market?

Market.US has segmented the Brucellosis Vaccines market by geographic (North America, Europe, APAC, South America, and Middle East and Africa). By Product Type the market has been segmented into RBS1 Vaccine, S19 Vaccine, Others. By Vaccine Type the market has been segmented into DNA Vaccine, Subunit Vaccine, Vector Vaccine, Recombinant Vaccine. By Application the market has been segmented into Cattle, Sheep & Goat, Others. By Distribution Channel the market has been segmented into Veterinary Hospitals & Clinics, Retail Channels, Others.

List the key industry players of the Brucellosis Vaccines market?

Merck & Co., CZ Vaccines, Colorado Serum Company, Indian Immunologicals, Hester Biosciences, Veterinary Technologies Corporation, Laboratorios Tornel, Fivet Animal Health, VETAL Animal Health Products Inc., and Other Key Players

Which region is more appealing for vendors employed in the Brucellosis Vaccines market?

North America is expected to account for the highest revenue share of 42.5% and boasting an impressive market value of USD 102.8 million. Therefore, the Brucellosis Vaccines industry in North America is expected to garner significant business opportunities over the forecast period.

Name the key areas of business for Brucellosis Vaccines?

The US, Canada, India, China, UK, Japan, & Germany are key areas of operation for the Brucellosis Vaccines Market.

Global Brucellosis Vaccines Market Analysis By Product Type (RBS1 Vaccine, S19 Vaccine, Others), By Vaccine Type (DNA Vaccine, Subunit Vaccine, Vector Vaccine, Recombinant Vaccine), By Application (Cattle, Sheep & Goat, Others), By Distribution Channel (Veterinary Hospitals & Clinics, Retail Channels, Others), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

Published date: Dec 2023
Report ID: 13430
Number of Pages: 262
Format:

- 1. Brucellosis Vaccines Market Introduction
  - 1.1. Definition
  - 1.2. Taxonomy
  - 1.3. Research Scope
- 2. Executive Summary
  - 2.1. Key Findings by Major Segments
  - 2.2. Top strategies by Major Players
- 3. Global Brucellosis Vaccines Market Overview
  - 3.1. Brucellosis Vaccines Market Dynamics
    
    3.1.1. Drivers
    
    3.1.2. Opportunities
    
    3.1.3. Restraints
    
    3.1.4. Challenges
  - 3.2. PESTLE Analysis
  - 3.3. Opportunity Map Analysis
  - 3.4. PORTER'S Five Forces Analysis
  - 3.5. Market Competition Scenario Analysis
  - 3.6. Product Life Cycle Analysis
  - 3.7. Opportunity Orbits
  - 3.8. Manufacturer Intensity Map
- 4. Global Brucellosis Vaccines Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
  - 4.1. Global Brucellosis Vaccines Market Analysis by Type: Introduction
  - 4.2. Market Size and Forecast by Region
  - 4.3. S19 Vaccine
  - 4.4. RB51 Vaccine Strain
  - 4.5. Other
- 5. Global Brucellosis Vaccines Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
  - 5.1. Global Brucellosis Vaccines Market Analysis by Application: Introduction
  - 5.2. Market Size and Forecast by Region
  - 5.3. Cattle
  - 5.4. Sheep
  - 5.5. Other
- 6. Global Brucellosis Vaccines Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
  - 6.1. North America
    
    6.1.1. North America Brucellosis Vaccines Market: Regional Trend Analysis
    
    6.1.1.1. US
    
    6.1.1.2. Canada
    
    6.1.1.3. Mexico
  - 6.2.1. Europe
    
    6.2.1. Europe Brucellosis Vaccines Market: Regional Trend Analysis
    
    6.2.1.1. Germany
    
    6.2.1.2. France
    
    6.2.1.3. UK
    
    6.2.1.4. Russia
    
    6.2.1.5. Italy
    
    6.2.1.6. Spain
    
    6.2.1.7. Rest of Europe
  - 6.3. Asia-Pacific
    
    6.3.1. Asia-Pacific Brucellosis Vaccines Market: Regional Trend Analysis
    
    6.3.1.1. China
    
    6.3.1.2. Japan
    
    6.3.1.3. Korea
    
    6.3.1.4. India
    
    6.3.1.5. Rest of Asia
  - 6.4. Latin America
    
    6.4.1. Latin America Brucellosis Vaccines Market: Regional Trend Analysis
    
    6.4.1.1. Brazil
    
    6.4.1.2. Argentina
    
    6.4.1.3. Rest of Latin America
  - 6.5. Middle East and Africa
    
    6.5.1. Middle East and Africa Brucellosis Vaccines Market: Regional Trend Analysis
    
    6.5.1.1. GCC
    
    6.5.1.2. South Africa
    
    6.5.1.3. Israel
    
    6.5.1.4. Rest of MEA
- 7. Global Brucellosis Vaccines Market Competitive Landscape, Market Share Analysis, and Company Profiles
  - 7.1. Market Share Analysis
  - 7.2. Company Profiles
  - 7.3. Jinyu
    
    7.3.1. Company Overview
    
    7.3.2. Financial Highlights
    
    7.3.3. Product Portfolio
    
    7.3.4. SWOT Analysis
    
    7.3.5. Key Strategies and Developments
  - 7.4. Colorado Serum
    
    7.4.1. Company Overview
    
    7.4.2. Financial Highlights
    
    7.4.3. Product Portfolio
    
    7.4.4. SWOT Analysis
    
    7.4.5. Key Strategies and Developments
  - 7.5. Boehringer Ingelheim
    
    7.5.1. Company Overview
    
    7.5.2. Financial Highlights
    
    7.5.3. Product Portfolio
    
    7.5.4. SWOT Analysis
    
    7.5.5. Key Strategies and Developments
  - 7.6. Biogenesis-Bago
    
    7.6.1. Company Overview
    
    7.6.2. Financial Highlights
    
    7.6.3. Product Portfolio
    
    7.6.4. SWOT Analysis
    
    7.6.5. Key Strategies and Developments
  - 7.7. Vetal Company
    
    7.7.1. Company Overview
    
    7.7.2. Financial Highlights
    
    7.7.3. Product Portfolio
    
    7.7.4. SWOT Analysis
    
    7.7.5. Key Strategies and Developments
  - 7.8. CZ Veterinaria
    
    7.8.1. Company Overview
    
    7.8.2. Financial Highlights
    
    7.8.3. Product Portfolio
    
    7.8.4. SWOT Analysis
    
    7.8.5. Key Strategies and Developments
  - 7.9. SYVA Laboratorios
    
    7.9.1. Company Overview
    
    7.9.2. Financial Highlights
    
    7.9.3. Product Portfolio
    
    7.9.4. SWOT Analysis
    
    7.9.5. Key Strategies and Developments
  - 7.10. Indian Immunologicals
    
    7.10.1. Company Overview
    
    7.10.2. Financial Highlights
    
    7.10.3. Product Portfolio
    
    7.10.4. SWOT Analysis
    
    7.10.5. Key Strategies and Developments
  - 7.11. Qilu
    
    7.11.1. Company Overview
    
    7.11.2. Financial Highlights
    
    7.11.3. Product Portfolio
    
    7.11.4. SWOT Analysis
    
    7.11.5. Key Strategies and Developments
  - 7.12. Tecnovax
    
    7.12.1. Company Overview
    
    7.12.2. Financial Highlights
    
    7.12.3. Product Portfolio
    
    7.12.4. SWOT Analysis
    
    7.12.5. Key Strategies and Developments
  - 7.13. Hester Biosciences
    
    7.13.1. Company Overview
    
    7.13.2. Financial Highlights
    
    7.13.3. Product Portfolio
    
    7.13.4. SWOT Analysis
    
    7.13.5. Key Strategies and Developments
  - 7.14. Zoetis
    
    7.14.1. Company Overview
    
    7.14.2. Financial Highlights
    
    7.14.3. Product Portfolio
    
    7.14.4. SWOT Analysis
    
    7.14.5. Key Strategies and Developments
  - 7.15. Onderstepoort Biological
    
    7.15.1. Company Overview
    
    7.15.2. Financial Highlights
    
    7.15.3. Product Portfolio
    
    7.15.4. SWOT Analysis
    
    7.15.5. Key Strategies and Developments
  - 7.16. Instituto Rosenbusch
    
    7.16.1. Company Overview
    
    7.16.2. Financial Highlights
    
    7.16.3. Product Portfolio
    
    7.16.4. SWOT Analysis
    
    7.16.5. Key Strategies and Developments
  - 7.17. Ceva Sante Animale
    
    7.17.1. Company Overview
    
    7.17.2. Financial Highlights
    
    7.17.3. Product Portfolio
    
    7.17.4. SWOT Analysis
    
    7.17.5. Key Strategies and Developments
  - 7.18. Calier & Biologicos Laverlam
    
    7.18.1. Company Overview
    
    7.18.2. Financial Highlights
    
    7.18.3. Product Portfolio
    
    7.18.4. SWOT Analysis
    
    7.18.5. Key Strategies and Developments
  - 7.19. Biovet
    
    7.19.1. Company Overview
    
    7.19.2. Financial Highlights
    
    7.19.3. Product Portfolio
    
    7.19.4. SWOT Analysis
    
    7.19.5. Key Strategies and Developments
- 8. Assumptions and Acronyms
- 9. Research Methodology
- 10. Contact
- Merck & Co.
- CZ Vaccines
- Colorado Serum Company
- Indian Immunologicals
- Hester Biosciences
- Veterinary Technologies Corporation
- Laboratorios Tornel
- Fivet Animal Health
- VETAL Animal Health Products Inc.
Settings

Related Reports

Our Clients

Inquiry Before Buying

Report ID 13430
Published Date Dec 2023
Rating
- ★★★★★
  
  ★★★★★
- (98)

Buy Now

Trusted by more than 17382 organizations globally

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $6,000 $3,999 USD / per unit save 24%	Multi User $8,000 $5,999 USD / per unit save 28%	Corporate User $10,000 $6,999 USD / per unit save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 3,999)	Buy Now ($ 5,999)	Buy Now ($ 6,999)